Proteomedix

Schlieren, Switzerland

Proteomedix (an Onconetix company; NASDAQ:ONCO) is a healthcare company whose mission is to transform prostate cancer diagnosis.

Sep 2021

Debt Financing

Top Investors

Altos VenturesZürcher Kantonal BankVenture KickNew Horizon HealthAltos Venture

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Proteomedix's investors?

Proteomedix's investors include Altos Ventures, Zürcher Kantonal Bank, Venture Kick, New Horizon Health, Altos Venture.

Where is Proteomedix headquartered?

Proteomedix is headquartered in Schlieren, Switzerland.

What does Proteomedix do?

Proteomedix (an Onconetix company; NASDAQ:ONCO) is a healthcare company whose mission is to transform prostate cancer diagnosis.

What stage is Proteomedix at?

Proteomedix is at the Debt Financing stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 21, 2021.

MLA

"Proteomedix — Funding & Investors." VCBacked, September 21, 2021, https://www.vcbacked.co/company/proteomedix. Accessed July 1, 2026.

APA

VCBacked. (2021). Proteomedix — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/proteomedix

Wikipedia (cite web)

{{cite web |title=Proteomedix — Funding & Investors |url=https://www.vcbacked.co/company/proteomedix |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 21, 2021.